Meanwhile, NS-treated and PDL1-treated mice all died within 21 d after tumor inoculation, while only 2 mice in the rM-FC and anti-PDL1 combination treatment group died within 40 d (n = 6), and the mouse survival rate increased to 67% (Fig. 6F). This evidence concerns the gene CD274 and neoplasm.